Recent Updates
Recently added Catalysts
LNTH Positive Sentiment

Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time

Wednesday, July 23, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Lantheus Holdings, Inc. has announced it will host a conference call and webcast on August 6, 2025, at 8:00 a.m. Eastern Time to discuss its financial results for the second quarter of 2025. Participants are encouraged to register in advance to avoid delays. A replay of the call will be available shortly after its conclusion and archived for 30 days. This event highlights Lantheus's commitment to transparency and investor engagement.
Price reaction · baseline $72.34 (2025-07-22 close) · hit after-hours · clean, no other LNTH news in the window
day 0 close · peak
+1.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus continues to proactively update investors about its financial status.
  • The company emphasizes its long-standing expertise in radiopharmaceuticals.
  • The availability of a webcast replay ensures accessibility for interested parties.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

BEDFORD, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, August 6, 2025, to discuss its financial results and provide a business update for the second quarter of 2025.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Switzerland and Sweden, Lantheus has been providing radiopharmaceutical solutions for nearly 70 years. For more information, visit www.lantheus.com.

Frequently Asked Questions

When is the Lantheus conference call for Q2 2025?

The conference call for Q2 2025 is scheduled for August 6, 2025, at 8:00 a.m. ET.

How can I access the Lantheus conference call?

Participants can access the call by registering online at the Lantheus investor website.

Is there a replay available for the conference call?

Yes, a replay will be available about two hours after the event and archived for 30 days.

What does Lantheus Holdings specialize in?

Lantheus Holdings specializes in radiopharmaceuticals to improve patient outcomes.

Where is Lantheus Holdings headquartered?

Lantheus Holdings is headquartered in Bedford, Massachusetts.

ShareAdd on Google
Tags: LNTH Viatris Investor Conferences Healthcare Lantheus radiopharmaceuticals earnings call biopharma
Last updated: Jul 23, 2025

Biotech snapshot

Cash runway
$593M liquidity · $0M/mo burn
Low dilution risk
Lead asset
18F-DCFPyLPhase 3
Prostate Cancer →

Catalyst track record

+48%
best trade around LNTH's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for LNTH.

See every catalyst's timing & PoA →